SCHEMBL24079190

SCHEMBL24079190

CCCCc1nc2ccccc2c(O)c1C(C)O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.42
ALDH1A1 P00352 4/20 0.42
GAA P10253 2/20 0.42
PARP1 P09874 1/20 0.42
LMNA P02545 1/20 0.41
MAPK1 P28482 1/20 0.41
HPGD P15428 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.40
ADORA3 P0DMS8 1/20 0.39
ADORA2A P29274 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
TSHR P16473 1/20 0.39
HSD17B10 Q99714 1/20 0.39
DHODH Q02127 1/20 0.38
TLR8 Q9NR97 3/20 0.38
TLR7 Q9NYK1 2/20 0.38
PDE4A P27815 1/20 0.38
PDE4B Q07343 1/20 0.38
PDE4C Q08493 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19841056 1.00 KDM4E (0.42) KDM4EALDH1A1GAAPARP1LMNA
SCHEMBL5369158 0.77 KDM4E (0.49) KDM4EALDH1A1GAALMNAHPGD
SCHEMBL29365110 0.77 KDM4E (0.49) KDM4EALDH1A1GAALMNAHPGD
SCHEMBL4189659 0.77 KDM4E (0.49) KDM4EALDH1A1GAALMNAHPGD
SCHEMBL22042252 0.75 KDM4E (0.45) KDM4EALDH1A1GAAPARP1LMNA
SCHEMBL27941270 0.74 TLR8 (0.49) KDM4EALDH1A1GAALMNAHPGD
SCHEMBL29539238 0.74 KMT2A (0.56) KDM4EALDH1A1GAAPARP1LMNA
SCHEMBL7823737 0.73 GPR3 (0.42) KDM4EALDH1A1GAAPARP1LMNA
SCHEMBL2566789 0.72 BID (0.46) KDM4EALDH1A1GAALMNAHPGD
SCHEMBL14952438 0.71 BID (0.48) KDM4EALDH1A1GAALMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11192866-B2 Synthesis of tetracyclines and analogues thereof PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2021-12-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11192866-B2 Synthesis of tetracyclines and analogues thereof TET1, TET3, MYC KDM4E 800/4885ALDH1A1 4455/4885GAA 570/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.